Poly Medicure (POLYMED.NS) Stock Price

Poly Medicure Price

NSE·CLOSED
1,708.50INR-15.60 (-0.91 %)
Market closed

Revenue has compounded at 18.9% per year over the past 17 years to 16.70 B INR. Earnings per share have grown at 24.2% per year over the last 17 years. Poly Medicure's net margin stands at 20.3%, up from 17.3% several years earlier. Poly Medicure currently offers a dividend yield of about 0.20%. The payout ratio is around 10% of earnings. The dividend has grown at 1.2% per year over the past 13 years. Analysts set a median price target of 2,228.70 INR, implying 30.4% above the current price. Of 11 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 43% above its 52-week low.

Poly Medicure stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Poly Medicure over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Poly Medicure stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Poly Medicure's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Poly Medicure Stock Price History
DatePoly Medicure Price
8/5/20261,708.50 INR
8/4/20261,724.10 INR
7/31/20261,702.00 INR
7/30/20261,668.30 INR
7/28/20261,669.30 INR
7/24/20261,664.00 INR
7/23/20261,650.40 INR
7/22/20261,674.40 INR
7/21/20261,695.90 INR
7/20/20261,720.90 INR
7/17/20261,680.50 INR
7/16/20261,722.70 INR
7/15/20261,715.60 INR
7/14/20261,664.40 INR
7/13/20261,651.60 INR
7/10/20261,668.30 INR
7/9/20261,645.90 INR
7/8/20261,614.30 INR
7/7/20261,669.70 INR
7/6/20261,687.80 INR
7/3/20261,675.10 INR
7/2/20261,732.30 INR
7/1/20261,666.10 INR
6/30/20261,687.40 INR
6/29/20261,652.60 INR
6/25/20261,650.20 INR
6/24/20261,650.90 INR
6/23/20261,650.00 INR
6/22/20261,671.40 INR
6/19/20261,580.00 INR
6/18/20261,536.00 INR
6/17/20261,527.00 INR
6/16/20261,520.00 INR
6/15/20261,528.60 INR
6/12/20261,504.90 INR
6/11/20261,416.60 INR
6/10/20261,418.50 INR
6/9/20261,458.80 INR
6/8/20261,382.80 INR
6/5/20261,411.40 INR
6/4/20261,405.00 INR
6/3/20261,339.20 INR
6/2/20261,321.40 INR
6/1/20261,347.70 INR
5/29/20261,324.10 INR
5/27/20261,388.00 INR
5/26/20261,443.90 INR
5/25/20261,580.50 INR
5/22/20261,564.40 INR
5/21/20261,489.60 INR
5/20/20261,439.40 INR
5/19/20261,455.10 INR
5/18/20261,452.20 INR
5/15/20261,498.90 INR
5/14/20261,521.00 INR
5/13/20261,597.70 INR
5/12/20261,671.10 INR
5/11/20261,650.80 INR
5/8/20261,652.10 INR
5/7/20261,679.90 INR
5/6/20261,655.60 INR
5/5/20261,596.80 INR
5/4/20261,527.80 INR
5/1/20261,512.10 INR
4/30/20261,512.10 INR
4/29/20261,517.90 INR
4/28/20261,511.70 INR
4/27/20261,495.60 INR
4/24/20261,414.20 INR
4/23/20261,488.00 INR
4/22/20261,473.20 INR
4/21/20261,480.50 INR
4/20/20261,456.30 INR
4/17/20261,467.40 INR
4/16/20261,496.90 INR
4/15/20261,472.40 INR
4/13/20261,453.10 INR
4/10/20261,462.30 INR
4/9/20261,438.80 INR
4/8/20261,440.40 INR
4/7/20261,390.00 INR
4/6/20261,370.10 INR
4/2/20261,334.20 INR
4/1/20261,283.20 INR
3/30/20261,191.10 INR
3/27/20261,230.10 INR
3/25/20261,302.60 INR
3/24/20261,244.30 INR
3/23/20261,206.10 INR
3/20/20261,240.90 INR
3/19/20261,240.50 INR
3/18/20261,279.10 INR
3/17/20261,241.40 INR
3/16/20261,255.60 INR
3/13/20261,260.20 INR
3/12/20261,312.30 INR
3/11/20261,333.40 INR
3/10/20261,283.60 INR
3/9/20261,318.60 INR
3/6/20261,356.10 INR
3/5/20261,360.00 INR
3/4/20261,398.40 INR
3/2/20261,314.00 INR
2/27/20261,256.10 INR
2/26/20261,258.70 INR
2/25/20261,299.20 INR
2/24/20261,287.10 INR
2/23/20261,268.80 INR
2/20/20261,255.80 INR
2/19/20261,278.30 INR
2/18/20261,308.00 INR
2/17/20261,321.90 INR
2/16/20261,300.80 INR
2/13/20261,289.20 INR
2/12/20261,316.50 INR
2/11/20261,387.60 INR
2/10/20261,485.70 INR
2/9/20261,462.50 INR
2/6/20261,389.40 INR
2/5/20261,502.50 INR
2/4/20261,517.20 INR
2/3/20261,586.90 INR
2/2/20261,450.60 INR
1/30/20261,520.90 INR
1/29/20261,505.70 INR
1/28/20261,513.80 INR
1/27/20261,515.10 INR
1/23/20261,590.00 INR
1/22/20261,609.00 INR
1/21/20261,571.20 INR
1/20/20261,625.70 INR
1/19/20261,649.50 INR
1/16/20261,644.90 INR
1/15/20261,666.80 INR
1/14/20261,666.80 INR
1/13/20261,713.50 INR
1/12/20261,752.10 INR
1/9/20261,776.30 INR
1/8/20261,776.90 INR
1/7/20261,800.80 INR
1/6/20261,787.60 INR
1/5/20261,724.30 INR
1/2/20261,769.70 INR
1/1/20261,742.50 INR
12/31/20251,773.70 INR
12/30/20251,698.70 INR
12/29/20251,740.50 INR
12/26/20251,756.80 INR
12/24/20251,784.50 INR
12/23/20251,799.80 INR
12/22/20251,800.80 INR
12/19/20251,810.30 INR
12/18/20251,796.80 INR
12/17/20251,848.00 INR
12/16/20251,852.10 INR
12/15/20251,873.70 INR
12/12/20251,889.80 INR
12/11/20251,880.80 INR
12/10/20251,887.90 INR
12/9/20251,909.30 INR
12/8/20251,858.10 INR
12/5/20251,899.10 INR
12/4/20251,910.80 INR
12/3/20251,916.90 INR
12/2/20251,925.20 INR
12/1/20251,932.00 INR
11/28/20251,939.10 INR
11/27/20251,967.40 INR
11/26/20251,899.40 INR
11/25/20251,908.80 INR
11/24/20251,925.50 INR
11/21/20251,876.90 INR
11/20/20251,879.10 INR
11/19/20251,893.20 INR
11/18/20251,899.30 INR
11/17/20251,943.70 INR
11/14/20251,943.00 INR
11/13/20251,958.90 INR
11/12/20252,025.30 INR
11/11/20252,063.40 INR
11/10/20251,862.30 INR
11/7/20251,893.80 INR
11/6/20251,896.90 INR
11/4/20251,955.20 INR
11/3/20251,914.60 INR
10/31/20251,999.70 INR
10/30/20251,974.10 INR
10/29/20251,968.50 INR
10/28/20251,905.60 INR
10/27/20251,902.00 INR
10/24/20251,922.00 INR
10/23/20251,923.10 INR
10/21/20251,934.70 INR
10/20/20251,879.40 INR
10/17/20251,905.20 INR
10/16/20251,920.50 INR
10/15/20251,838.30 INR
10/14/20251,857.20 INR
10/13/20251,864.70 INR
10/10/20251,896.00 INR
10/9/20251,901.60 INR
10/8/20251,911.00 INR
10/7/20251,854.50 INR
10/6/20251,897.60 INR
10/3/20251,910.80 INR
10/1/20251,951.00 INR
9/30/20251,948.10 INR
9/29/20251,934.00 INR
9/26/20251,959.50 INR
9/25/20252,031.80 INR
9/24/20251,983.10 INR
9/23/20251,952.90 INR
9/22/20251,956.20 INR
9/19/20251,996.20 INR
9/18/20252,065.40 INR
9/17/20251,996.60 INR
9/16/20251,989.40 INR
9/15/20251,983.60 INR
9/12/20252,022.20 INR
9/11/20251,995.70 INR
9/10/20251,947.60 INR
9/9/20252,004.90 INR
9/8/20252,018.20 INR
9/5/20252,041.80 INR
9/4/20252,033.10 INR
9/3/20252,067.00 INR
9/2/20252,077.60 INR
9/1/20252,071.60 INR
8/29/20252,085.40 INR
8/28/20252,101.00 INR
8/26/20252,078.10 INR
8/25/20252,121.80 INR
8/22/20252,070.60 INR
8/21/20251,964.70 INR
8/20/20251,966.80 INR
8/19/20251,900.40 INR
8/18/20251,899.60 INR
8/14/20251,902.40 INR
8/13/20251,846.30 INR
8/12/20251,922.70 INR
8/11/20251,974.10 INR
8/8/20251,927.40 INR
Access this data via the Eulerpool API
Get Free API Key

Poly Medicure Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
9.23 B INR
1.59 B INR
1.47 B INR
Jan 1, 2023
11.15 B INR
2.09 B INR
1.79 B INR
Jan 1, 2024
13.76 B INR
2.95 B INR
2.58 B INR
Jan 1, 2025
16.70 B INR
3.70 B INR
3.39 B INR
Jan 1, 2026 (e)
18.82 B INR
5.86 B INR
3.50 B INR
Jan 1, 2027 (e)
23.70 B INR
7.38 B INR
3.81 B INR
Jan 1, 2028 (e)
28.07 B INR
8.74 B INR
4.70 B INR
Jan 1, 2029 (e)
30.70 B INR
9.56 B INR
5.89 B INR

Poly Medicure Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 8:28 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
EBITB INR
EBIT MARGIN%
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
3.223.904.124.625.226.116.877.869.2311.1513.7616.7018.8223.7028.0730.70
24.0721.145.6112.0312.9517.1012.5114.4417.3720.8223.3721.3712.7125.9218.469.37
65.2761.7562.6954.8956.4455.4558.4357.2253.0754.3356.0757.7057.7057.7057.7057.70
2.102.412.582.542.943.394.024.504.906.067.719.6310.8613.6716.2017.71
0.650.650.650.680.910.921.241.671.592.092.953.705.867.388.749.56
20.0216.7315.7014.7217.4815.1117.9721.2217.2518.7021.4122.1831.1331.1331.1331.13
0.450.620.480.550.710.650.961.361.471.792.583.393.503.814.705.89
85.9538.44-22.6314.3227.95-7.2346.4841.757.8822.3244.0831.103.438.6823.5025.39
4.002.504.001.501.502.002.002.502.503.003.003.503.503.503.50–
100.00-37.5060.00-62.50–33.33–25.00–20.00–16.67––––
88.2088.2088.2088.2088.2088.2088.2089.2096.0096.0296.0299.2499.2499.2499.2499.24
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Poly Medicure generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Poly Medicure retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Poly Medicure's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Poly Medicure has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Poly Medicure's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Poly Medicure stock margins

The Poly Medicure margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Poly Medicure. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Poly Medicure.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
57.22 %
21.23 %
17.28 %
Jan 1, 2022
53.07 %
17.25 %
15.87 %
Jan 1, 2023
54.33 %
18.70 %
16.08 %
Jan 1, 2024
56.08 %
21.42 %
18.77 %
Jan 1, 2025
57.70 %
22.18 %
20.27 %
Jan 1, 2026 (e)
57.70 %
31.13 %
18.60 %
Jan 1, 2027 (e)
57.70 %
31.13 %
16.06 %
Jan 1, 2028 (e)
57.70 %
31.13 %
16.74 %

Poly Medicure Stock Revenue, EBIT, Earnings per Share

The Poly Medicure earnings per share therefore indicates how much revenue Poly Medicure has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
88.17 INR
18.72 INR
15.23 INR
Jan 1, 2022
96.15 INR
16.59 INR
15.26 INR
Jan 1, 2023
116.14 INR
21.72 INR
18.67 INR
Jan 1, 2024
143.28 INR
30.68 INR
26.90 INR
Jan 1, 2025
168.26 INR
37.32 INR
34.11 INR
Jan 1, 2026 (e)
185.68 INR
59.04 INR
34.54 INR
Jan 1, 2027 (e)
233.81 INR
74.35 INR
37.54 INR
Jan 1, 2028 (e)
276.97 INR
88.07 INR
46.36 INR

Poly Medicure business model & stock analysis

Poly Medicure Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Poly Medicure historical P/E ratio, EBIT multiple, and P/S ratio

Poly Medicure annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Poly Medicure shares outstanding

The number of shares of Poly Medicure was 99.24 M in 2025. This indicates how many shares Poly Medicure is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
89.20 M Stocks
Jan 1, 2022
96.00 M Stocks
Jan 1, 2023
96.02 M Stocks
Jan 1, 2024
96.02 M Stocks
Jan 1, 2025
99.24 M Stocks
Jan 1, 2026 (e)
99.24 M Stocks
Jan 1, 2027 (e)
99.24 M Stocks
Jan 1, 2028 (e)
99.24 M Stocks

Poly Medicure stock splits

In Poly Medicure's history, there have been no stock splits.

Poly Medicure Dividend History

14 years of dividend payments

YearAnnual DividendYoY ChangePayments
20253.50INR↑ 16.7%1×
Sep 18, 20253.50INR↑ 16.7%1/1
20243.00INR 0.0%1×
20233.00INR↑ 20.0%1×
20222.50INR 0.0%1×
20212.50INR↑ 25.0%1×
20202.00INR 0.0%1×
20192.00INR 0.0%1×
20182.00INR↑ 33.3%1×
20171.50INR↓ 62.5%2×
20164.00INR↑ 60.0%3×

Poly Medicure dividend history and estimates

In 2025, Poly Medicure paid a dividend amounting to 3.50 INR. Dividend means that Poly Medicure distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021 (e)
0.00 INR
2.50 INR
Jan 1, 2022
2.50 INR
0.00 INR
Jan 1, 2023
3.00 INR
0.00 INR
Jan 1, 2024
3.00 INR
0.00 INR
Jan 1, 2025
3.50 INR
0.00 INR
Jan 1, 2026
3.50 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
3.50 INR
Jan 1, 2028 (e)
0.00 INR
3.50 INR

Poly Medicure dividend payout ratio

In 2025, Poly Medicure had a payout ratio of 10.26%. The payout ratio indicates the percentage of the company's profits that Poly Medicure distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
16.40 %
Jan 1, 2022
16.37 %
Jan 1, 2023
16.07 %
Jan 1, 2024
11.15 %
Jan 1, 2025
10.26 %
Jan 1, 2026 (e)
10.13 %
Jan 1, 2027 (e)
9.32 %
Jan 1, 2028 (e)
7.55 %

Current Poly Medicure forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.80 %
Buy
72.73 % (8)
Hold
27.27 % (3)
Sell
0.00 % (0)
12M Price Target
2,228.70
Last Price
1,709.30
Currency
INR
12M Return Potential
30.39 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Poly Medicure stock

57/100
44
Environment
78
Social
49
Governance
E

Environment

20
Scope 1 - Direct Emissions2,319.85
Scope 2 - Indirect emissions from purchased energy33,962.28
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions36,282.13
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Poly Medicure shareholder structure

% Name
3.51582%
Quant Money Managers Ltd
Quant Money Managers Ltd
1.94354%
UTI Asset Management Co. Ltd.
UTI Asset Management Co. Ltd.
1.14412%
White Oak Capital Management Consultants Llp
White Oak Capital Management Consultants Llp
1.07964%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.04121%
abrdn Asia Limited
abrdn Asia Limited
0.68163%
SBI Funds Management Pvt. Ltd.
SBI Funds Management Pvt. Ltd.

Poly Medicure Beneficial Ownership Filings (SEC 13D/G)

Free Float
33.1%
Float Shares
-
Shares Outstanding
-

Poly Medicure Executives and Management Board

15 members · avg. age 62 · 7 % women

SB

Shri. Himanshu Baid (57)

Managing Director, Executive Director

214.23 M INR

Management

SB

Shri. Rishi Baid (53)

Joint Managing Director, Executive Director · since 2014

209.30 M INR
SV

Shri. Naresh Vijayvargiya (67)

Chief Financial Officer

–
SC

Shri. Avinash Chandra

Compliance Officer, Company Secretary

–
SP

Shri. Ravi Prakash

Deputy Company Secretary

–

Board of Directors

SB

Shri. Alessandro Balboni (63)

Non-Executive and Non Independent Director

28.24 M INR
DM

Mr. Devendra Mehta (88)

Non-Executive and Non-Independent Chairman of the Board

2.28 M INR
SM

Smt. Sonal Mattoo (50)

Non-Executive Independent Director

2.28 M INR
SK

Shri. Amit Khosla (50)

Non-Executive Independent Director

2.18 M INR
SB

Shri. Jugal Baid (83)

Non Executive and Non Independent Director

2.08 M INR
AM

Dr. Ambrish Mithal (67)

Non-Executive Independent Director

2.05 M INR

Frequently asked questions about Poly Medicure

Analysts currently set an average price target of 2,195.72 INR for the Poly Medicure stock (median: 2,228.70 INR), implying +28.5 % versus the latest price. The consensus is based on 11 analyst ratings.

Poly Medicure Analyst Price Targets 2026

11 analysts currently rate the Poly Medicure stock: 8 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Poly Medicure to generate revenue of 18.82 B INR and earnings per share of 35.28 INR.

Poly Medicure Analyst Price Targets 2026

Converted at the current exchange rate, the Poly Medicure share trades at 15.56 EUR (1,708.50 INR).

No history available for Poly Medicure.

The expected revenue of Poly Medicure is 18.82 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Poly Medicure is 3.50 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Poly Medicure is currently 48.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Poly Medicure stock.

The price-to-sales ratio (P/S) of Poly Medicure is currently 9.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Poly Medicure stock.

The Eulerpool Quality Score for Poly Medicure is 8/10.

The ISIN of Poly Medicure is INE205C01021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Poly Medicure is POLYMED.NS. The ticker symbol is used to trade Poly Medicure shares on the stock exchange.

Over the past 12 months, Poly Medicure paid a dividend of 3.50 INR . This corresponds to a dividend yield of about 0.20 %. For the coming 12 months, Poly Medicure is expected to pay a dividend of 3.50 INR.

The current dividend yield of Poly Medicure is 0.20 %.

Poly Medicure pays a dividend, distributed in the months of , , , .

Poly Medicure paid dividends every year for the past 14 years.

For the upcoming 12 months, dividends amounting to 3.50 INR are expected. This corresponds to a dividend yield of 0.20 %.

Poly Medicure is assigned to the 'Health' sector.

To receive the latest dividend of Poly Medicure from amounting to 3.5 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Poly Medicure distributed 3 INR as dividends.

The dividends of Poly Medicure are distributed in INR.

All fundamentals and in-depth analysis of Poly Medicure

Our stock analysis for Poly Medicure stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Poly Medicure. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Poly Medicure Stock
Poly Medicure Revenue→
Poly Medicure Stock
Poly Medicure Net Income→
Poly Medicure Stock
Poly Medicure P/E→
Poly Medicure Stock
Poly Medicure P/S→
Poly Medicure Stock
Poly Medicure EBIT→
Poly Medicure Stock
Poly Medicure Dividend→
Poly Medicure Stock
Poly Medicure Directors Dealings→
Poly Medicure Stock
Poly Medicure Stocks→
Poly Medicure Stock
Poly Medicure Market capitalization→
Poly Medicure Stock
Poly Medicure Debt→
Poly Medicure Stock
Poly Medicure Liabilities→
Poly Medicure Stock
Poly Medicure Equity→
Poly Medicure Stock
Poly Medicure AAQS→
Poly Medicure Stock
Poly Medicure Employees→
Poly Medicure Stock
Poly Medicure ROE→
Poly Medicure Stock
Poly Medicure ROA→
Poly Medicure Stock
Poly Medicure ROCE→
Poly Medicure Stock
Poly Medicure News→
Poly Medicure Stock
Poly Medicure Analyst Price Targets→

Health Stocks

Polylite Taiwan CoPolaryx Therapeutics, Inc. Common StockPolynovoPolaris Group LLCPolyPeptide GroupPolaris AI PharmaPolyrizonPMV PharmaceuticalsPOMDOCTOR LIMITED American Depositary SharesPlus TherapeuticsPoniard PharmaceuticalsPluriAll Stocks A–Z →